Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Supplementation and Timing in mNC-FET
NCT03795220Phase 4Completed
- Start
- Jan 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone in infertility. Primary endpoint: Live birth rates per transfer at 1 year. Started Jan 2019; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03795220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03795220.